USPTO Director Signals Continued Pro-Patent Discretionary Denial Policy at the Patent Trial and Appeal Board
Key Takeaway: In a precedential decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc., USPTO Director Squires denied IPR institution and reinforced the policy framework for discretionary denial at the...
Federal Circuit Review | April 2026
April Federal Circuit Newsletter (Japanese) April Federal Circuit Newsletter (Chinese) Invisible But Invalidating: Undisclosed Functionality Still Triggers On-Sale BarĀ In Definitive Holdings, LLC v. Powerteq LLC, Appeal No. 24-1761,...
Kregg Koch Discusses How Medtech Innovators Can Build a Stronger IP Strategy Through Patent Filing, Portfolio Development, and AI
In an article published by nonprofit educational medtech incubator Fogarty Innovation, Knobbe Martens partner Kregg Koch shared practical strategies for medtech companies and entrepreneurs looking to protect and maximize the...